JM Stassen

Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits

D Collen, JM Stassen, G Larsen · Blood · 1988 · 92 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions

Jolán Hársfalvi, JM Stassen, E Van Houtte et al. · Blood · 1995 · 61 citations · Full text

Medicine, Biochemistry, Hemostasis +10

Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin- specific antibody fused to single-chain urokinase

Paul Holvoet, Yves Laroche, JM Stassen et al. · Blood · 1993 · 44 citations · Full text

Pharmacy, Molecular Biology, Pharmacokinetics +17

Influence of fibrin and liver blood flow on the turnover and the systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator in rabbits

H Bounameaux, JM Stassen, C Seghers et al. · Blood · 1986 · 35 citations · Full text

Medicine, Bioengineering, Hemostasis +11

Effect of chemical conjugation of recombinant single-chain urokinase- type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo

M Dewerchin, HR Lijnen, JM Stassen et al. · Blood · 1991 · 31 citations · Full text

Medicine, Pharmaceutical Biotechnology, Antibody Engineering +16